Great Basin Scientific Inc. (GBSN) 4.98 $GBSN
Great Basin Scientific (GBSN) Stock Soars Today on FDA Clearance for Molecular Diagnostic Test
at The Street - Wed Apr 22, 1:43PM CDT
Shares of Great Basin Scientific (GBSN) soared Wednesday after the molecular diagnostic company announced that the FDA had granted clearance for a molecular diagnostic test.
GBSN: 4.98 (+1.44)
BUYINS.NET: GBSN SqueezeTrigger Price is $3.79. There is $1,575 That Short Sellers Still Need To Cover.
M2 - Wed Apr 22, 12:26PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Great Basin Scientific (NASDAQ:GBSN) in real time and just received an alert that GBSN is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $3.79. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:45AM CDT
AEC: 28.49 (+4.01), SMCI: 31.90 (-2.91), CAMP: 20.87 (+4.19), GEVO: 2.78 (+0.77), DSKX: 1.64 (+0.30), CCIH: 14.86 (+2.54), ENZN: 1.70 (+0.20), NRP: 5.54 (-1.38), PARN: 4.19 (-0.30), GBSN: 4.98 (+1.44), AMSC: 10.40 (+1.20), PW: 6.33 (-2.95), EARS: 4.65 (-0.75), EMMS: 1.61 (-0.24), COOL: 1.40 (-0.21), LOOK: 1.75 (-0.51), ONVO: 5.14 (+0.67), HMNY: 2.90 (-0.63), PKT: 11.42 (+1.91), ZHNE: 1.89 (+0.36)
Premarket Gainers / Losers as of 9:15 am
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 8:15AM CDT
BRCM: 46.18 (+2.20), CSLT: 7.85 (+0.36), NVGN: 7.40 (-0.30), ASML: 107.81 (+10.06), VICL: 1.01 (-0.02), NRP: 5.54 (-1.38), ENZN: 1.70 (+0.20), GBSN: 4.98 (+1.44), LOOK: 1.75 (-0.51), ONVO: 5.14 (+0.67), CMG: 641.23 (-51.29), ANGI: 6.46 (+0.31), PKT: 11.42 (+1.91)
FDA clears Great Basin diagnostic test; shares up 37% premarket
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 8:12AM CDT
GBSN: 4.98 (+1.44)
Great Basin Receives FDA 510(k) Clearance for Group B Strep Molecular Diagnostic Test
PR Newswire - Wed Apr 22, 7:00AM CDT
Great Basin Scientific, Inc. (NASDAQ: GBSN and GBSNU), a molecular diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its molecular diagnostic test for Group B Streptococcus (GBS). This is Great Basin's second assay to be cleared by the FDA. The Company's first test, for Clostridium difficile, or C. diff, was approved in May 2012. Great Basin plans to launch the GBS assay commercially in the second quarter of 2015.
GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15)
Health Care Stock Check: Complementary Research on ARCA Biopharma, Great Basin, Corium International, Alphatech Holdings, Akers Biosciences
PR Newswire - Fri Apr 17, 7:15AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ATEC: 1.41 (+0.01), CORI: 9.09 (+0.42), GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15), AKER: 4.55 (+0.05), ABIO: 0.88 (+0.01)
Great Basin Scientific (GBSN) Stock Continues to Rise Today on Increase in U.S. Customers
at The Street - Tue Apr 14, 9:00AM CDT
Shares of Great Basin Scientific (GBSN) continued to climb today, one day after the molecular diagnostic company reported quarter-over-quarter growth in the number of revenue-generating customers in the U.S.
GBSN: 4.98 (+1.44)
BUYINS.NET: GBSN SqueezeTrigger Price is $3.71. There is $1,353 That Short Sellers Still Need To Cover.
M2 - Mon Apr 13, 10:22AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring GIBSON CRYOGENICS IN (NASDAQ:GBSN) in real time and just received an alert that GBSN is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $3.71. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
GBSN: 4.98 (+1.44)
Great Basin Scientific (GBSN) Stock Rises Today After Announcing Increased Number of Customers
at The Street - Mon Apr 13, 9:38AM CDT
Shares of Great Basin Scientific (GBSN) rose Monday after the molecular diagnostic company reported quarter-over-quarter growth in the number of revenue-generating customers in the U.S.
GBSN: 4.98 (+1.44)
Great Basin's customer base up 20%; Shares rise
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 8:39AM CDT
GBSN: 4.98 (+1.44)
Great Basin Reports 101 U.S. Customers to End First Quarter, Reaffirms Guidance for 2015 Customer Acquisition
PR Newswire - Mon Apr 13, 7:00AM CDT
Great Basin Scientific, Inc. (NASDAQ: GBSN; GBSNU), a molecular diagnostics company, today announced continued growth in the number of customers using its sample-to-result molecular diagnostic technology during the first quarter of 2015. The Company reported a total of 101 revenue-generating customers in the United States as of March 31, 2015, a 20% increase over the 84 customers reported as of the prior quarter ending December 31, 2014. Customer evaluations, which represent the Company's sales pipeline, have seen a matched increase of 20% over the fourth quarter of 2014 from 43 active and scheduled evaluations to 52 at the end of the first quarter of 2015.
GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15)
Is Great Basin Scientific Just Another Pump And Dump?
The GeoTeam - Seeking Alpha - Wed Apr 08, 12:57PM CDT
GeoInvesting is currently short Great Basic Scientific (NASDAQ: GBSN ), a rapid diagnostic medical test (Nucleic Acid Assay Testing) firm. We first alerted GeoInvesting premium members that we identified red flags associated with GBSN on March 30,...
GNMK: 10.51 (-0.22), GBSN: 4.98 (+1.44), BDX: 144.33 (-1.24), VIVO: 18.89 (+0.01), QDEL: 23.80 (+0.64), CPHD: 53.14 (-0.78), TTOO: 16.10 (-1.15), QGEN: 24.93 (-0.15), HOLX: 33.26 (-0.07), NSPH: 4.05 (+0.10)
Sell Great Basin Scientific Inc., Penny Stock Newsletter Pumps Don't End Well
Big Banks - at Seeking Alpha - Mon Apr 06, 2:31PM CDT
GNMK: 10.51 (-0.22), GBSN: 4.98 (+1.44), RCAP: 8.49 (-0.08), QDEL: 23.80 (+0.64), CPHD: 53.14 (-0.78), RTGN: 3.67 (-0.27)
Great Basin Scientific to Present at the 2nd Annual Growth Capital Expo
PR Newswire - Mon Apr 06, 7:00AM CDT
Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, announced today that co-founder and CEO Ryan Ashton will present at the 2nd Annual Growth Capital Expo at 2:00 p.m. PDT April 13 at Caesars Palace in Las Vegas, NV. Management will also be available for investor meetings on April 13 and 14.
GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15)
Great Basin Scientific (GBSN) Stock Soars Today on FDA Clearance for Molecular Diagnostic Test
at The Street - Wed Apr 22, 1:43PM CDT
Shares of Great Basin Scientific (GBSN) soared Wednesday after the molecular diagnostic company announced that the FDA had granted clearance for a molecular diagnostic test.
GBSN: 4.98 (+1.44)
BUYINS.NET: GBSN SqueezeTrigger Price is $3.79. There is $1,575 That Short Sellers Still Need To Cover.
M2 - Wed Apr 22, 12:26PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Great Basin Scientific (NASDAQ:GBSN) in real time and just received an alert that GBSN is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $3.79. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:45AM CDT
AEC: 28.49 (+4.01), SMCI: 31.90 (-2.91), CAMP: 20.87 (+4.19), GEVO: 2.78 (+0.77), DSKX: 1.64 (+0.30), CCIH: 14.86 (+2.54), ENZN: 1.70 (+0.20), NRP: 5.54 (-1.38), PARN: 4.19 (-0.30), GBSN: 4.98 (+1.44), AMSC: 10.40 (+1.20), PW: 6.33 (-2.95), EARS: 4.65 (-0.75), EMMS: 1.61 (-0.24), COOL: 1.40 (-0.21), LOOK: 1.75 (-0.51), ONVO: 5.14 (+0.67), HMNY: 2.90 (-0.63), PKT: 11.42 (+1.91), ZHNE: 1.89 (+0.36)
Premarket Gainers / Losers as of 9:15 am
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 8:15AM CDT
BRCM: 46.18 (+2.20), CSLT: 7.85 (+0.36), NVGN: 7.40 (-0.30), ASML: 107.81 (+10.06), VICL: 1.01 (-0.02), NRP: 5.54 (-1.38), ENZN: 1.70 (+0.20), GBSN: 4.98 (+1.44), LOOK: 1.75 (-0.51), ONVO: 5.14 (+0.67), CMG: 641.23 (-51.29), ANGI: 6.46 (+0.31), PKT: 11.42 (+1.91)
FDA clears Great Basin diagnostic test; shares up 37% premarket
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 8:12AM CDT
GBSN: 4.98 (+1.44)
Great Basin Receives FDA 510(k) Clearance for Group B Strep Molecular Diagnostic Test
PR Newswire - Wed Apr 22, 7:00AM CDT
Great Basin Scientific, Inc. (NASDAQ: GBSN and GBSNU), a molecular diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its molecular diagnostic test for Group B Streptococcus (GBS). This is Great Basin's second assay to be cleared by the FDA. The Company's first test, for Clostridium difficile, or C. diff, was approved in May 2012. Great Basin plans to launch the GBS assay commercially in the second quarter of 2015.
GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15)
Health Care Stock Check: Complementary Research on ARCA Biopharma, Great Basin, Corium International, Alphatech Holdings, Akers Biosciences
PR Newswire - Fri Apr 17, 7:15AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ATEC: 1.41 (+0.01), CORI: 9.09 (+0.42), GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15), AKER: 4.55 (+0.05), ABIO: 0.88 (+0.01)
Great Basin Scientific (GBSN) Stock Continues to Rise Today on Increase in U.S. Customers
at The Street - Tue Apr 14, 9:00AM CDT
Shares of Great Basin Scientific (GBSN) continued to climb today, one day after the molecular diagnostic company reported quarter-over-quarter growth in the number of revenue-generating customers in the U.S.
GBSN: 4.98 (+1.44)
BUYINS.NET: GBSN SqueezeTrigger Price is $3.71. There is $1,353 That Short Sellers Still Need To Cover.
M2 - Mon Apr 13, 10:22AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring GIBSON CRYOGENICS IN (NASDAQ:GBSN) in real time and just received an alert that GBSN is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $3.71. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
GBSN: 4.98 (+1.44)
Great Basin Scientific (GBSN) Stock Rises Today After Announcing Increased Number of Customers
at The Street - Mon Apr 13, 9:38AM CDT
Shares of Great Basin Scientific (GBSN) rose Monday after the molecular diagnostic company reported quarter-over-quarter growth in the number of revenue-generating customers in the U.S.
GBSN: 4.98 (+1.44)
Great Basin's customer base up 20%; Shares rise
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 8:39AM CDT
GBSN: 4.98 (+1.44)
Great Basin Reports 101 U.S. Customers to End First Quarter, Reaffirms Guidance for 2015 Customer Acquisition
PR Newswire - Mon Apr 13, 7:00AM CDT
Great Basin Scientific, Inc. (NASDAQ: GBSN; GBSNU), a molecular diagnostics company, today announced continued growth in the number of customers using its sample-to-result molecular diagnostic technology during the first quarter of 2015. The Company reported a total of 101 revenue-generating customers in the United States as of March 31, 2015, a 20% increase over the 84 customers reported as of the prior quarter ending December 31, 2014. Customer evaluations, which represent the Company's sales pipeline, have seen a matched increase of 20% over the fourth quarter of 2014 from 43 active and scheduled evaluations to 52 at the end of the first quarter of 2015.
GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15)
Is Great Basin Scientific Just Another Pump And Dump?
The GeoTeam - Seeking Alpha - Wed Apr 08, 12:57PM CDT
GeoInvesting is currently short Great Basic Scientific (NASDAQ: GBSN ), a rapid diagnostic medical test (Nucleic Acid Assay Testing) firm. We first alerted GeoInvesting premium members that we identified red flags associated with GBSN on March 30,...
GNMK: 10.51 (-0.22), GBSN: 4.98 (+1.44), BDX: 144.33 (-1.24), VIVO: 18.89 (+0.01), QDEL: 23.80 (+0.64), CPHD: 53.14 (-0.78), TTOO: 16.10 (-1.15), QGEN: 24.93 (-0.15), HOLX: 33.26 (-0.07), NSPH: 4.05 (+0.10)
Sell Great Basin Scientific Inc., Penny Stock Newsletter Pumps Don't End Well
Big Banks - at Seeking Alpha - Mon Apr 06, 2:31PM CDT
GNMK: 10.51 (-0.22), GBSN: 4.98 (+1.44), RCAP: 8.49 (-0.08), QDEL: 23.80 (+0.64), CPHD: 53.14 (-0.78), RTGN: 3.67 (-0.27)
Great Basin Scientific to Present at the 2nd Annual Growth Capital Expo
PR Newswire - Mon Apr 06, 7:00AM CDT
Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, announced today that co-founder and CEO Ryan Ashton will present at the 2nd Annual Growth Capital Expo at 2:00 p.m. PDT April 13 at Caesars Palace in Las Vegas, NV. Management will also be available for investor meetings on April 13 and 14.
GBSN: 4.98 (+1.44), GBSNU: 15.40 (+1.15)
